Harrow Q3 Earnings Preview: This Business Has Eye-Popping Potential

If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe to my weekly newsletter via my Investing Group, Haggerston BioHealth ?With its Q3 earnings due to be reported in five days' time, on tenth November, I thought this would be a good time to initiate my first coverage of Harrow Inc, an ophthalmology company with seemingly strong growth p ...